Balasubramanian Dorairajan
Director/Board Member at Bharat Biotech International Ltd.
Balasubramanian Dorairajan active positions
| Companies | Position | Start | End |
|---|---|---|---|
Bharat Biotech International Ltd.
 Bharat Biotech International Ltd. BiotechnologyHealth Technology Bharat Biotech International Ltd. engages in research and development, manufacturing, marketing and distribution of vaccines and biotherapeutics. It focuses on the development of novel health care solutions for region-specific neglected diseases. The firm offers Revac-B+, REGEN-D, HNVAC, COMVAC5, BIOPOLIO, INDIRAB, Typbar TCV, BIOHIB, JENVAC, ROTAVAC and vaccine candidates against chikungunya, chandipura, HPV and Ebola. The company was founded by Krishna Murthy Ella and Suchitra K. Ella in 1996 and is headquartered in Hyderabad, India.. | Director/Board Member | 2015-03-30 | - |
Career history of Balasubramanian Dorairajan
Former positions of Balasubramanian Dorairajan
| Companies | Position | Start | End |
|---|---|---|---|
| VIMTA LABS LIMITED | Director/Board Member | 2004-07-11 | 2019-03-30 |
| Independent Dir/Board Member | 2004-07-11 | 2019-03-30 | |
| Center for Cellular & Molecular Biology | Director/Board Member | - | - |
Training of Balasubramanian Dorairajan
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
Statistics
International
| India | 4 |
| United States | 2 |
Operational
| Director/Board Member | 3 |
| Independent Dir/Board Member | 1 |
| Doctorate Degree | 1 |
Sectoral
| Consumer Services | 3 |
| Commercial Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| VIMTA LABS LIMITED | Commercial Services |
| Private companies | 1 |
|---|---|
Bharat Biotech International Ltd.
Bharat Biotech International Ltd. BiotechnologyHealth Technology Bharat Biotech International Ltd. engages in research and development, manufacturing, marketing and distribution of vaccines and biotherapeutics. It focuses on the development of novel health care solutions for region-specific neglected diseases. The firm offers Revac-B+, REGEN-D, HNVAC, COMVAC5, BIOPOLIO, INDIRAB, Typbar TCV, BIOHIB, JENVAC, ROTAVAC and vaccine candidates against chikungunya, chandipura, HPV and Ebola. The company was founded by Krishna Murthy Ella and Suchitra K. Ella in 1996 and is headquartered in Hyderabad, India.. | Health Technology |
